[GlobeNewswire] - NEW YORK -- NeoStem, Inc. ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced the pricing of an underwritten public offering of 5,000,000 ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment